Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celularity (CELU) Operating Expenses (2020 - 2025)

Celularity has reported Operating Expenses over the past 6 years, most recently at $26.2 million for Q4 2025.

  • Quarterly Operating Expenses fell 4.56% to $26.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $87.9 million through Dec 2025, down 5.1% year-over-year, with the annual reading at $87.9 million for FY2025, 5.1% down from the prior year.
  • Operating Expenses was $26.2 million for Q4 2025 at Celularity, up from $18.2 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $103.0 million in Q3 2023 and troughed at -$13.4 million in Q4 2022.
  • The 5-year median for Operating Expenses is $22.0 million (2024), against an average of $28.5 million.
  • Year-over-year, Operating Expenses surged 30542.6% in 2021 and then tumbled 167.43% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $19.8 million in 2021, then tumbled by 167.43% to -$13.4 million in 2022, then surged by 90.99% to -$1.2 million in 2023, then soared by 2378.64% to $27.4 million in 2024, then fell by 4.56% to $26.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Operating Expenses are $26.2 million (Q4 2025), $18.2 million (Q3 2025), and $21.6 million (Q2 2025).